Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Directorate Change

4 Jul 2025 12:49

RNS Number : 8278P
Ceiba Investments Limited
04 July 2025
 

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

APPOINTMENT OF NON-EXECUTIVE DIRECTORS

 

Further to RNS announcement number 4152G released by the Company on 28 April 2025, the Company is pleased to announce the appointment of Dena Bellamy, Mary Dunphy and Robin Smith as independent, non-executive directors of the Company with effect from 3 July 2025.

 

Dena Bellamy is an experienced corporate finance professional with over 25 years of experience in investment banking. After completing her Ph.D., she embarked on a career that saw her work at international financial institutions including Rothschild, Merrill Lynch, and Commerzbank. Dena has provided strategic advice on M&A transactions, IPOs, and bond issuance to clients in a range of sectors, including real estate and infrastructure. Dena has held board director roles in both public and private companies, including Biofarma Innovations, a joint venture with BioCubaFarma, the Cuban state-owned pharmaceutical company. She has also recently spent a number of years working on the establishment of a new international investment bank in Cuba.

 

Mary Dunphy, a law graduate from Trinity College, has held numerous positions as a Chairperson and Board member of Private, Listed and Global Not-for-profits organisations and on a pro bono for international and national charities. Most recently she has chaired two Nasdaq listed companies. Previously she was a Global Equity Partner / Senior Managing Director at both Accenture & Teneo (Global Board & C-Suite Advisory). She worked with C-Suite teams, boards and VC / PE investors of high profile and FTSE100 organisations; on defining and delivering double digit EBITDA and valuation improvements. Mary was the Global CEO of CoderDojo: a charity she activated and led in 65 countries. Mary is an experienced keynote speaker at global events including at the World Economic Forum at Davos, The Web Summit, SouthxSouthWest, Salesforce World Tour & Dreamforce, EU Parliament and Buckingham Palace. She is also a multi award recipient and media presenter.

 

Robin Smith is a Fellow of the Chartered Association of Certified Accountants (FCCA) who was educated in Guernsey, studied accountancy in the UK and trained professionally with Deloitte, Haskins & Sells in London. He is also a member of the Society of Trust and Estate Practitioners (STEP). From 1984 until 2024, Mr Smith held senior positions with three fiduciary groups, first with Havelet and Nerine where he performed a variety of roles including Company Secretary and Group Finance Director with board appointments on their principal Guernsey based fiduciary and fund operations. Most recently until February 2024 he was Managing Director of the Praxis Guernsey Fiduciary business until his retirement in February 2024. He is a non-executive Director of a UK Charity, Servol Community Services Limited and is a Non-Executive Director of each of Darwin Property Investment Management Limited and Darwin Alternative Investment Management Limited who between them manage three Guernsey Open Ended Class B Collective Investment Schemes. 

 

Details of all directorships held by each of Dena, Mary and Robin in other publicly quoted companies are as follows:

 

Director

Current Directorships

Previous Directorships

Dena Bellamy

Equipmake Holdings plc

n/a

Mary Dunphy

n/a

Mashup Ireland AB

Robin Smith

n/a

n/a

 

Dena, Mary and Robin will also be appointed as members of the Company's Audit Committee, Nomination Committee and Management Engagement Committee.

 

John Herring, Chairman of the Company, commented:

 

"We are extremely pleased to welcome Dena, Mary and Robin on to the Board. Each of them brings significant skills, knowledge and a fresh perspective to the Board and we look forward to working with them going forward."

 

This announcement has been made in accordance with the requirements of 6.4.6 and 6.48 of the UK Listing Rules.

 

A further announcement regarding the successor of the role of Senior Independent Director which was previously fulfilled by Keith Corbin who retired from the Board at the Company's Annual General Meeting on 3 July 2025, will be made in due course.

 

For further information, please contact:

 

John Herring

 

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Patrick Weaver (Corporate Finance)

 

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

 

 

www.ceibainvest.com

 

 

END OF ANNOUNCEMENT

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUACMUPAGGC
12
Date   Source Headline
3rd Jul 20234:41 pmRNSUpdate re Internalisation of Management
28th Jun 20236:16 pmRNSResult of AGM
28th Jun 20236:05 pmRNSNet Asset Value(s)
27th Apr 20234:03 pmRNSAnnual Financial Report - Replacement
27th Apr 20237:00 amRNSInternalisation of Management
27th Apr 20237:00 amRNSAnnual Financial Report
7th Feb 20231:07 pmRNSHolding(s) in Company
14th Dec 20221:14 pmRNSCorrection: Half-year Report
1st Dec 20227:00 amRNSService Providers and Registered Office
30th Nov 202212:22 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
1st Aug 20224:53 pmRNSAlternative Investment Fund Manager–Change of Name
4th Jul 202210:02 amRNSNet Asset Value(s)
16th Jun 20225:34 pmRNSResult of AGM
25th May 20223:38 pmRNSCorrection: Annual Financial Report
29th Apr 20229:45 amRNSAnnual Financial Report
23rd Feb 20227:00 amRNSNet Asset Value(s)
22nd Feb 20227:00 amRNSTrading Update
19th Jan 20224:48 pmRNSHolding(s) in Company
31st Dec 20211:27 pmRNSHolding(s) in Company
31st Dec 20211:26 pmRNSHolding(s) in Company
26th Nov 20214:34 pmRNSHolding(s) in Company
26th Nov 20213:24 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
28th Sep 20217:00 amRNSHalf-year Report
17th Jun 20212:47 pmRNSResult of AGM
28th Apr 20217:00 amRNSAnnual Financial Report
14th Apr 20217:00 amRNSListing of Convertible Bonds
31st Mar 202112:16 pmRNSTrading Statement
15th Jan 20217:00 amRNSNet Asset Value(s)
16th Dec 20207:00 amRNSTrading Statement
3rd Dec 20204:30 pmRNSResult of Extraordinary Meeting
13th Nov 20207:00 amRNSNotice of EGM
23rd Oct 20207:00 amRNSTrading Statement
9th Oct 20204:59 pmRNSHalf-year Report
29th Sep 20207:00 amRNSHalf-year Report
19th Jun 20204:00 pmRNSResult of AGM
8th Jun 20207:00 amRNSTrading Statement
20th May 20205:40 pmRNSNet Asset Value(s)
28th Apr 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSTrading Statement
3rd Dec 20193:37 pmRNSChange of Auditor
6th Nov 201912:32 pmRNSNet Asset Value(s)
30th Sep 20197:00 amRNSHalf-year Report
18th Jun 20195:27 pmRNSResult of AGM
13th Jun 20194:38 pmRNSHolding(s) in Company
11th Jun 201910:53 amRNSPublication of Supplementary Prospectus
3rd Jun 201912:59 pmRNSTrading Statement
29th May 201911:29 amRNSNet Asset Value(s)
30th Apr 20195:40 pmRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.